'Salvage cytoreductive surgery for pelvic side wall recurrent endometrial cancer: Robotic combined laterally extended endopelvic resection (LEER) and laterally extended pelvic resection (LEPR) debulking'

Endometrial cancer is the most common gynecological malignancy, and most patients present at an early-stage. However, approximately 15% of confined-uterus endometrial cancer patients will see their cancer return. Treatment options for recurrent endometrial cancer depend on the patient’s level of fitness, tumor dissemination and prior treatment. For localized resectable pelvic disease, salvage cytoreductive surgery may improve survival.1 Laterally extended endopelvic resection, en-bloc resection of the pelvic tumor and sidewall structures, represents an option for salvage treatment in cases of isolated recurrence involving the pelvic side wall.2